AUPH INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi for Certain Forms of Relapsed or Refractory Large B-cell Lymphoma Pharmaceutical Investing
Allergan, an AbbVie Company, Announces Positive Topline Phase 3 Results Evaluating Investigational Twice-Daily Administration of VUITY 1.25% in Adults with Age-Related Blurry Near Vision Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo with Chemotherapy as First-Line Treatment for Patients with... Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo Plus Yervoy as First-Line Treatment for Patients with... Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo as Adjuvant Treatment for Patients with Radically Resected, High-Risk Muscle-Invasive Urothelial Carcinoma with Tumor Cell PD-L1 Expression ?1% Pharmaceutical Investing
Merck Investor Event Today Will Highlight Broad and Growing Cardiovascular Portfolio and Pipeline in Areas of Unmet Patient Need Life Science Investing
Aurinia Pharmaceuticals Announces Presentations at the 2022 National Kidney Foundation Spring Clinical Meetings Pharmaceutical Investing
Resorts World Las Vegas Secures First-of-its-Kind Agreement With Allergan Aesthetics Pharmaceutical Investing
Abbott Receives FDA Approval for Aveir VR Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms Pharmaceutical Investing
